Bispecific ADC

Advertisement

cGxPJobs Banner

Akeso Starts Phase II Trial of AK146D1 for Advanced NSCLC

HONG KONG, July 20, 2026 Akeso, Inc. has announced a significant milestone in its oncology pipeline with the first...

By cGxPwire Editor
July 21, 2026

Read More

Advertisement

cGxPJobs

Directory